Clinical trial
Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
NCT03781050 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- September 16, 2018
- Completion date
- July 1, 2022
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.